Physician-led healthcare advisory, since 2020

Healthcare strategy, from Central Europe to the Middle East.

Vogler Group is a physician-led advisory firm. We help providers, payers, medtech companies and investors decide where to compete and what to own, and we stay involved until the decision is working in the business.

Discuss a mandate Our capabilities

Offices in Klagenfurt am Wörthersee, Tübingen and LjubljanaRelationships in Riyadh, Abu Dhabi and Doha

Group businesses

Vogler GroupHealthcare strategy, M&A advisory and management consulting.Our capabilities Vogler MedRegenerative sports medicine and cross-border care.Visit Vogler Med Medical device distributionAuthorised distribution of medical devices in Slovenia, Croatia and Austria, with physician-led clinical introduction.Visit medical device distribution

Capabilities

Strategy is the core of the firm. Our M&A and management consulting work grows out of it, so the thinking behind a decision stays with the client through the transaction and into operations.

Strategy

Core practice

We help healthcare leaders decide where to compete and how to win there, with the regulatory and reimbursement reality of each market built into the answer from the start.

Where we help

Corporate and portfolio strategy for private providers, payers, medtech companies and investors
Market entry and expansion, from market sizing to partner and distributor selection
Service line and network strategy for hospitals and clinic groups
Product and channel strategy for private health insurers
Business model design for digital health and platform businesses
Reimbursement and policy scenarios, including long-term care reform

Questions clients bring us

Which markets justify a direct presence, and which are better served through a partner?

How will a single-payer system respond to a new service line or device?

M&A advisory

Sell-side and buy-side advice on healthcare transactions, led by people who read a clinical operation as closely as a set of accounts.

Where we help

Sell-side mandates, from preparation and equity story to competitive two-stage processes
Buy-side advice, from target screening through valuation to negotiation
Commercial and clinical due diligence
Buyer mapping across strategic acquirers and financial sponsors
Support for financial sponsors building healthcare platforms
Sell-side origination in Slovenian private healthcare, in partnership with CorSapio

Questions clients bring us

Who are the credible buyers for a specialist provider in this region, and what will they pay for?

What does clinical due diligence show that the financial model cannot?

Management consulting

Hands-on work inside provider groups and payers once the strategy or the transaction is set, measured against operating and financial targets agreed at the start.

Where we help

Performance improvement programmes for private hospitals and clinic groups
Operational efficiency in surgical and outpatient pathways
Clinical governance and quality systems
Back-office professionalisation for smaller providers, through a management services model adapted to a single-payer system

Questions clients bring us

Where is margin lost between the operating theatre and the invoice?

Which back-office functions should a small provider share, and which should it keep?

Our partner in Slovenia

CorSapio

In Slovenia, Vogler Group works as a partner of CorSapio, a Ljubljana advisory firm of 50+ professionals in financial, tax, legal, process, digital and EU-funding advisory. Together we work the Slovenian private healthcare market systematically rather than deal by deal.

Strategy

Market mapping

A bottom-up screen of Slovenian private healthcare providers that frames each owner's strategic options before any process starts.

M&A advisory

Sell-side origination

For owners considering a sale, we map strategic and financial buyers with CorSapio and run a competitive two-stage process, from teaser to signing.

Management consulting

Back-office professionalisation

For providers not yet ready to sell, we offer shared professional back-office functions through a management services model built for the ZZZS single-payer system. It strengthens the business today and prepares it for a transaction later.

corsapio.com

Where we work

Our home ground is where Central Europe meets the Balkans. From offices in Klagenfurt am Wörthersee, Tübingen and Ljubljana we work across both regions, and our advisory work reaches into the Middle East through Riyadh, Abu Dhabi and Doha.

Central and Eastern Europe

Anchored in Slovenia, Austria and Germany, where most of our advisory work has been done.

Strategy

Product and channel strategy in private health insurance
Expansion strategy for private hospitals
Market entry for healthcare technology

M&A advisory

Sell-side and buy-side M&A for private providers
Market mapping and sell-side origination in Slovenian private healthcare, with CorSapio

Management consulting

Performance improvement for private hospitals

The Balkans

Croatia and the Western Balkans, from market-entry strategy to transactions.

Strategy

Market entry for healthcare technology
Regulatory and reimbursement mapping for medical device entry

M&A advisory

Buy-side advice on private hospital acquisitions
Cross-border transaction work

The Middle East

Advisory work between European healthcare and the Gulf, with direct links to Riyadh, Abu Dhabi and Doha.

Strategy

Coverage of Saudi Arabia's Vision 2030 Health Sector Transformation Program in Riyadh, including the health-cluster model and medtech localisation
Market-entry and partnering strategy for European medtech and specialist care in the GCC

M&A advisory

A direct institutional relationship with the Abu Dhabi Investment Authority
Advice to Gulf investors and operators on healthcare assets and partnerships in Europe

How we work

Senior-led

The founder leads every engagement, from the first conversation to delivery.

Clinically grounded

A surgeon's training shapes how we test a service line or read a clinical due diligence.

An operator's view

The group runs its own care coordination and distribution businesses, so we also advise from the operator's side of the table.

Regional fluency

We work in Slovenian, German, Croatian and Serbian as well as English, and plan around how each regulator and payer actually operates.

Beyond advisory

Vogler Group also builds and runs healthcare businesses. They are managed separately from the advisory practice and give it an operator's perspective.

Vogler Med

Four services. A regenerative sports medicine platform in Ljubljana, inbound medical tourism across 7 hospitals in Austria, Slovenia and Croatia, port-side medical care for cruise passengers, and support for Slovenian patients treated in other EU hospitals.

Visit Vogler Med

Medical device distribution

Authorised distribution of medical devices and consumables for international manufacturers, with physician-led clinical introduction. Core markets are Slovenia, Croatia and Austria, with expansion into the Western Balkans, CEE and then MENA.

Visit medical device distribution

Consumer health

Personalised nutritional supplements developed with clinical and nutrigenomic research partners, sold through pharmacy and clinical channels.

Animal health

Veterinary supplements distributed through veterinary clinics and specialist retail.

About the firm

Jan Vogler, dr. med.

Founder, Chief Executive Officer and Managing Director

Vogler Group was established in 2020 as a healthcare strategy and M&A advisory firm, with offices in Klagenfurt am Wörthersee, Tübingen and Ljubljana.

Jan is a physician-executive. He trained in orthopaedic and spinal surgery at the University Medical Centre Ljubljana before moving into healthcare strategy and transactions, and has since built operator-led businesses alongside the advisory practice.

Medicine: Medical degree, University of Ljubljana, graduated as valedictorian
Surgery: Orthopaedic and spinal surgery training, University Medical Centre Ljubljana
Sports medicine: Team physician in professional football
Research: Texas Heart Institute, Houston
Executive education: Healthcare economics, Harvard Business School
The Gulf: Covers Saudi Arabia's Vision 2030 Health Sector Transformation Program in Riyadh. Direct institutional relationship with the Abu Dhabi Investment Authority
Languages: Slovenian, English, German, Croatian and Serbian

Vogler Med

Regenerative sports medicine and cross‑border care.

Four healthcare services: building a regenerative sports medicine platform in Ljubljana, alongside cross-border care coordination for international patients and cruise passengers treated in the region, and Slovenian patients treated in other EU hospitals.

Enquire Why Slovenia. Why Ortopedija Bedenčič.

1Regenerative sports medicine

Building Slovenia's regenerative sports medicine platform.

The platform strategy rests on a clinical anchor, an EU regulatory wedge and three customer flows we intend to capture.

Clinical lead: doc. dr. Klemen Bedenčič, dr. med.
Strategy: Jan Vogler, dr. med.
Horizon: 2026 to 2031

Elite athletes fly to Madrid for care they cannot legally receive at home. We are building what they could not find in Ljubljana.

Platform strategy in depth

The thesis

Talent, regulation and geography align.

Elite athlete demand, EU ATMP regulatory cover, a senior clinical operator and one-to-two-hour flights from London.

Elite athletes a year (TAM)

200 to 400

With the means and medical sophistication to seek what we are building.

Regulatory cover

EU ATMP

Hospital exemption administered by JAZMP. Pharmaceutical-grade, traceable, defensible.

Clinical operator

Bedenčič

Slovenia's most published MSC orthopaedic surgeon. Senior, signing authority, defensible record.

Flight from London

1 to 2 hours

Reachable for an off-week NBA visit or an in-season EPL bye round.

Slovenia has the orthopaedic talent, the EU regulatory framework and the geographic position to build a credible elite regenerative sports medicine destination. Until now, it has not had the operator or the platform. Ortopedija Bedenčič, led by doc. dr. Klemen Bedenčič, dr. med., can be that platform.

Three converging customer flows

US professionals blocked by FDA cell-expansion rules
EU and CEE high-net-worth orthopaedic clients
Active ageing on the longevity pathway

The regulatory wedge

Different rules, equivalently rigorous.

What 21 CFR Part 1271 blocks in the United States, and what the EU hospital exemption permits in Ljubljana.

The defensibility of the platform sits on the asymmetry between FDA and EU rules. We are not arbitraging weak regulation. We are arbitraging different but equivalently rigorous regulation.

United States, constraint

21 CFR Part 1271

Any cellular product more than minimally manipulated, or used for a non-homologous function, is classified as a biological drug
Blocked outside FDA-authorised trials: cartilage regeneration, expanded MSCs, systemic IV cell infusion, donor-derived MSC products
US clinics limited to PRP, same-day BMAC and same-day autologous adipose procedures, or a legally exposed grey market

European Union, permission

Regulation (EC) No 1394/2007, hospital exemption

Custom-made ATMPs prepared on a non-routine basis for individual patients under medical prescription, authorised by JAZMP
Permitted: cultured autologous expanded MSCs, allogeneic cell products from EU-certified tissue banks, exosome and secretome preparations
Requires GMP-grade preparation, traceability, ethics oversight and pharmacovigilance. Pharmaceutical-grade by design

We can legally administer in Ljubljana what a US team physician cannot legally administer at home, with documented quality controls that reach pharmaceutical-grade standards.

Clinical platform

Three pillars, one roof.

Acute injury, chronic injury and degenerative care, with the clinical menu, customer and value proposition of each.

Same biology, same regulatory wrapper. Different customer profiles, time horizons and clinical pathways.

Pillar 1, acute

Acute injury.

Return to play.

Soft tissue with high time pressure on return to play. Hamstring and calf strains, partial muscle tears, ligament sprains.

Clinical menu: Image-guided PRP and PRP-leukocyte, cultured autologous MSC under JAZMP exemption, exosome adjuvants, HBOT, focused ultrasound, same-day BMAC where indicated.
Customer: Active professionals in season, with team physician sign-off. 7 to 14 day window.

Value propositionTime saved

Pillar 2, chronic

Chronic injury.

Career extension, post-injury maintenance.

Tendinopathies, partial tears unresolved by PRP, recurrent muscle injuries, post-surgical augmentation.

Clinical menu: Cultured autologous MSC over multi-week protocols, structured PRP and exosome cycles, biologic augmentation of arthroscopy, IV MSC for systemic anti-inflammatory effect.
Customer: Veteran professionals in the off-season, sub-elite competitors, masters athletes. 2 to 4 weeks on site.

Value propositionCareer years

Pillar 3, degenerative

Degenerative.

The general client backbone.

Osteoarthritis, cartilage defects, post-traumatic arthritis, peritendinous degeneration. The existing clinical strength of Ortopedija Bedenčič.

Clinical menu: Autologous MSC for OA at standardised indications, ACI-style cellular protocols where appropriate, viscosupplementation paired with cell therapy, structured outpatient pathway.
Customer: Western European, UK and CEE clients aged 45 to 75, avoiding total joint replacement. 3 to 7 days on site.

Value propositionJoint preservation

Patient journey

Two pathways, one operating standard.

The athlete pathway and the general client pathway, from first contact to follow-up.

Athlete and general client journeys diverge, but the documentation, traceability and follow-up discipline do not.

Athlete pathwayPillars 1 and 2

Inbound
Initial contact
Team physician, agent, federation or direct inquiry. Single clinical contact at Ortopedija Bedenčič. Language support at intake.
Triage
Remote case review
Remote review of existing imaging and team records. Recommendation in 48 hours. JAZMP eligibility confirmed.
Travel
Brnik arrival
Brnik pickup, central or quiet accommodation by profile, security and confidentiality protocol for high-recognition athletes.
On site
Treatment
Diagnostic workup with ultrasound and MRI, biological harvest day, processing and culture window, treatment day, structured rehab handover.
Follow-up
Remote monitoring
Clinical report to the team. Telehealth at 2, 6 and 12 weeks. MRI at 3 months when indicated. WADA-compliant documentation pack.

General client pathwayPillar 3

Inbound
Referral
Referring physician, longevity partner, insurance broker or direct digital. Triage to candidacy and pillar fit.
Tele-consult
Pre-arrival
Structured intake. Pre-arrival diagnostics summary. Pillar 3 protocol confirmed before travel.
On site
Treatment
Condensed diagnostic and treatment within 3 to 7 days. Single procedure in most cases. Accommodation coordinated.
Discharge
Home rehab
Structured home rehab programme. Clinical summary back to the referring physician. Outcome data captured for the registry.
Registry
Follow-up
Follow-up at 6 weeks and 6 months. Outcome data feeds the outcomes registry supporting ethics committee approvals.

Segmentation

Four segments, two engines.

Volume, per-case value, strategic role and channel for each segment, from Tier 1 sports to longevity.

Segment	Volume a year	Per-case value	Strategic role	Channel
Tier 1 sportsNBA, NFL, MLB, top-five European football	5 to 25	Highest	Brand, PR, signature cases	Team physicians, agents, agencies
Tier 2 sportsEuroLeague, second-tier football, Olympic	30 to 80	High	Volume and brand	Federations, sports medicine networks
General orthopaedic tourismUK, Germany, Scandinavia, CEE high-net-worth	200 to 500	Mid	Revenue base	Digital, partner clinics, brokers
Longevity and active ageingExecutive clientele, regional ultra-high-net-worth	50 to 150	Mid to high	Cross-sell to systemic IV MSC	Concierge, longevity clinic referrals

A single signed engagement with one NBA or NFL team's medical department, even on a single case, supplies us with reference value worth more than thirty general client cases. Tier 1 sports is the halo. The general client backbone funds the operation while we earn it.

Clinical leadership

The team behind the platform.

Clinical lead

doc. dr. Klemen Bedenčič, dr. med.

Specialist in orthopaedic surgery, Ortopedija Bedenčič, Ljubljana

Clinical lead for MSC therapy on the platform, with signing authority for JAZMP hospital exemption applications. He holds a permanent position at the General Hospital Novo mesto and works part-time at Kirurški sanatorij Rožna dolina in Ljubljana.

He graduated from the Faculty of Medicine in Ljubljana in 2010, completed his internship and went on to specialise in orthopaedic surgery, finishing in 2017. He obtained his doctorate from the University of Ljubljana in 2016. He trains continuously at international courses and in operating theatres in Belgium, France, Germany and Austria, mainly in foot surgery and arthroplasty.

In foot surgery, he has introduced numerous new treatment methods at the General Hospital Novo mesto. He regularly attends international congresses across Europe, including as a speaker, and publishes in recognised international journals. He was the first surgeon in Slovenia to implant an artificial big toe joint.

SpecialisationSurgical treatment of hip and knee osteoarthritis, including arthroplasty. Surgical treatment of the ankle and foot, including sports injuries of the ankle, ankle arthroscopy, Achilles tendon reconstruction, and correction of flatfoot and forefoot deformities.

ortopedija-bedencic.si

Strategy

Jan Vogler, dr. med.

CEO, Vogler Group. Vogler Med strategic lead

Physician-executive and orthopaedic surgery-trained founder of Vogler Group. Authors the commercial strategy, international business development model and investor structuring for the regenerative sports medicine platform. The Vogler Group partnership with Ortopedija Bedenčič covers international business development, M&A advisory and commercial structuring. A Harvard Business School healthcare economics background informs platform design and investor framing.

FocusPlatform strategy, international business development, Harvard Business School, orthopaedic surgery

The network

Why Slovenia. Why Ortopedija Bedenčič.

The country

Slovenia

EU member, Schengen, GDPR. JAZMP regulatory authority recognised across the EU ATMP framework. One to two hour flights from London, Munich, Frankfurt, Vienna, Milan, Rome and Zurich. Cost base materially below Germany and Switzerland.

The clinic

Ortopedija Bedenčič

The orthopaedic surgery practice of doc. dr. Klemen Bedenčič, dr. med., in central Ljubljana, with easy access from Brnik. Existing OA patient flow, a revenue-generating backbone that de-risks the elite vertical. A specialist orthopaedic practice with MSC therapy delivered under EU ATMP rules, never a longevity spa.

ortopedija-bedencic.si

The federations

Slovenian sports bodies

Slovenian Olympic, basketball, ski and handball federations as proximal partners. English-language fluency in clinical and administrative staff. Established relationships with team physicians across domestic and international sports organisations.

The referral network

7 hospitals and the Port of Koper

Vogler Med's existing hospital network across Austria, Slovenia and Croatia underpins inbound patient routing. 800 to 1,400 patients a year already coordinated. Cross-border concierge possible across SI, HR, SR, IT, DE and RU.

Make a referral or enquiry

2Inbound medical tourism

The Adriatic care network.

Vogler Med brings international patients to a network of 7 hospitals across Austria, Slovenia and Croatia. The platform handles provider contracting, patient triage, quality assurance, regulatory compliance and referral management. It operates as the commercial and clinical coordination layer between international patients and the regional hospital network.

The network serves patients across orthopaedics, surgery, rehabilitation and specialist medicine. English-language clinical and administrative coordination is provided throughout.

Patients a year, peak: 1,400
Hospital partners: 7
Countries: 3

What Vogler Med coordinates

Orthopaedic and surgical

Joint replacement, spinal surgery, sports medicine and reconstructive procedures across Slovenian and Croatian academic centres.

Specialist diagnostics

High-field MRI, advanced imaging and specialist clinical assessment, with turnaround times unavailable in patient home markets.

Rehabilitation

Post-surgical and injury rehabilitation at specialised CEE rehabilitation facilities. Concierge coordination and accommodation management.

Regenerative medicine

MSC therapy, PRP and biological augmentation under the EU ATMP hospital exemption. Slovenia's most published operator in this field.

Refer a patient

3Cruise port care

Medical care for cruise passengers.

Vogler Med provides port-side medical care for cruise passengers, starting at the Port of Koper with the 2027 cruise season and built to extend to further ports. Each unit sits within walking distance of the passenger terminal. When a ship's doctor decides that a passenger needs care ashore, we receive the patient, assess and stabilise, and treat on site wherever we can.

When hospital care is needed, an English-speaking companion escorts the patient to the regional hospital and stays with them throughout. We handle insurance pre-authorisation and documentation. The ship sails on, and the patient is never left alone.

Handled on site

Assess and treat

IV rehydration and electrolytes
Wound cleaning and suturing
ECG recording and interpretation
Point-of-care blood tests
Respiratory nebulisation
Medication administration

Hospital care

Assess and escort

Full triage assessment
Insurance pre-authorisation
Escort to hospital with an English-speaking companion
Staying with the patient to interpret and coordinate
Insurance documentation package
Discharge coordination

Not a walk-in clinic and not a spa. The missing operational link between a ship's infirmary and the local healthcare system, working with ships' medical officers and travel insurers.

Enquire about cruise port care

4Treatment in the EU

Waiting too long for a procedure?

When your waiting time in Slovenia exceeds the maximum permissible waiting time, you can be treated in a hospital in another EU member state and have the costs reimbursed by ZZZS, the Health Insurance Institute of Slovenia, under its rules for cross-border healthcare.

Vogler Med gives you access to quality, cost-effective treatment in EU hospitals. Our team supports you at every step of the journey, from checking your waiting time to travel and accommodation.

Procedures

Hip replacement
Knee replacement
Spinal surgery
Varicose vein surgery
Dental procedures
Other procedures

Questions patients ask

Do I need separate health insurance for treatment abroad?: No. If your waiting time exceeds the maximum permissible waiting time, you are entitled to have the costs reimbursed by ZZZS.
How do I find out my waiting time?: Waiting times are published by NIJZ, the National Institute of Public Health, and by individual providers. Our team checks the waiting time that applies in your case.
Do you help with travel and accommodation?: Yes. Organising travel and accommodation is at the core of what we do.

Ask about treatment in the EU Back to Vogler Group

Medical device distribution

Authorised CEE distributor. Physician‑led from day one.

We partner with international manufacturers whose products address genuine clinical needs in Slovenia, Croatia and Austria. Operational MDR economic operator infrastructure. Named hospital and private-clinic relationships. Clinical introduction by a Fellow of the American College of Cardiology.

Enquire What we provide

At a glance

Regulation: EU MDR 2017/745, Art. 30
Registration: JAZMP and HALMED registered
Traceability: UDI compliant
Quality: ISO 13485 partner
Core markets: Slovenia, Croatia and Austria
Expansion: Western Balkans and CEE, then MENA

What we provide

End-to-end distribution. No gaps.

Regulatory infrastructure

EU MDR Article 30 economic operator obligations. JAZMP (Slovenia) and HALMED (Croatia) product filings, and registration in the Austrian Register for Medical Devices. CE documentation review, UDI registration and EUDAMED entry. Post-market vigilance and complaint handling. Operational from the start of any partnership.

Clinical introduction

Prof. Igor D. Gregorič, MD, FACC, Chief of the Surgical Division at the Center for Advanced Heart Failure, UTHealth Houston and Memorial Hermann-TMC, and Fellow of the American College of Cardiology, leads clinical introductions and KOL engagement at major CEE academic centres and private cardiology clinics. Clinical relevance before commercial conversations.

Hospital access and tendering

Named relationships at public and private hospital procurement departments in Slovenia, Croatia and Austria. Active participation in hospital tender processes and pilot deployments at reference institutions.

Logistics and traceability

Lot traceability, cold-chain management where required, and warehouse infrastructure across Ljubljana with a secondary hub in Zagreb. Compliant with EU MDR post-market obligations. Field service through retained clinical specialists.

Reimbursement navigation

ZZZS (Slovenia) and HZZO (Croatia) reimbursement, and Austria's LKF hospital financing, mapped across all therapeutic categories we operate in. Submission support for inclusion in national positive lists. Pricing strategy within regulated tender frameworks.

Regional expansion

One entry model, carried from our core markets into the Western Balkans and CEE, and then into MENA. Our Slovenian and Croatian filings form the regulatory template for new markets.

Leadership

The team behind every partnership.

Founder

Jan Vogler, dr. med.

CEO and Managing Director, Vogler Group

Physician-executive with orthopaedic and spinal surgery training at UMC Ljubljana. Medical degree, University of Ljubljana (valedictorian). Executive education in healthcare economics, Harvard Business School. Runs all commercial, regulatory and partner relationships directly. 60+ client engagements across six CEE markets.

FocusUMC Ljubljana, Harvard Business School, strategy consulting, M&A advisory, 8+ years in CEE healthcare

FACC

Prof. Igor D. Gregorič, MD, FACC

Clinical co-founder and advisor, UTHealth Houston

Professor of Cardiothoracic and Vascular Surgery at McGovern Medical School, UTHealth Houston, and Chief and Program Director of the Surgical Division, Center for Advanced Heart Failure, Cardiopulmonary Support and Transplantation at Memorial Hermann-TMC, where he directs research and leads the adult ECMO and perfusion programmes.

Trained under Denton A. Cooley at the Texas Heart Institute, board-certified in thoracic surgery and author of more than 400 papers. A Ljubljana graduate, Honorary Professor at the Faculty of Medicine, University of Ljubljana, visiting professor at the Military Medical Academy in Belgrade and faculty at the Houston Shock Symposium. Fellow of the American College of Cardiology. Internationally recognised authority in cardiothoracic and cardiovascular surgery.

Leads all clinical introductions and KOL engagement across the Vogler Group distribution portfolio. His involvement is structural, not advisory in name only.

FocusUTHealth Houston, Memorial Hermann-TMC, FACC, cardiothoracic surgery, mechanical circulatory support, KOL engagement

Geographic footprint

Three core markets, one expansion path.

Core markets
Expansion
Beyond Europe
Offices in Klagenfurt am Wörthersee and Ljubljana

Core markets

Slovenia, Croatia and Austria

Served directly from our offices in Ljubljana and Klagenfurt am Wörthersee.
Expansion

Western Balkans and CEE

The same entry model, with our Slovenian and Croatian filings as the regulatory template.
Beyond Europe

Middle East and North Africa

The next step, drawing on the group's advisory presence in the Gulf.

Portfolio

What we distribute.

Our portfolio is not limited to set categories. We distribute medical devices and consumables of almost any kind, wherever a product meets a clinical need in our markets.

Product areas

Medical consumables
Mechanical circulatory support for heart failure, cardiology and remote monitoring, with KOL engagement led by Prof. Gregorič
Augmented reality systems
Navigation systems for surgery and interventional cardiology
Advanced pain management
Anaesthesia and critical care
Urology and gastroenterology
Other medical devices and consumables

Start a partnership conversation Back to Vogler Group

Contact

Write to us directly or prepare an email below. Enquiries are handled in confidence, and we usually reply within five working days.

info@voglergroup.com

Klagenfurt am WörtherseeAustria
TübingenGermany
LjubljanaSlovenia

Name

Organisation

Topic

Message

Prepare a draft addressed to info@voglergroup.com, then send it using your email app. This website does not send or store your message.

Healthcare strategy, from Central Europe to the Middle East.

Capabilities

Strategy

M&A advisory

Management consulting

CorSapio

Market mapping

Sell-side origination

Back-office professionalisation

Where we work

Central and Eastern Europe

The Balkans

The Middle East

How we work

Senior-led

Clinically grounded

An operator's view

Regional fluency

Beyond advisory

Vogler Med

Medical device distribution

Consumer health

Animal health

Jan Vogler, dr. med.

Regenerative sports medicine and cross‑border care.

Building Slovenia's regenerative sports medicine platform.

Talent, regulation and geography align.

Different rules, equivalently rigorous.

21 CFR Part 1271

Regulation (EC) No 1394/2007, hospital exemption

Three pillars, one roof.

Acute injury.

Chronic injury.

Degenerative.

Two pathways, one operating standard.

AAthlete pathwayPillars 1 and 2

Initial contact

Remote case review

Brnik arrival

Treatment

Remote monitoring

BGeneral client pathwayPillar 3

Referral

Pre-arrival

Treatment

Home rehab

Follow-up

Four segments, two engines.

The team behind the platform.

doc. dr. Klemen Bedenčič, dr. med.

Jan Vogler, dr. med.

Why Slovenia. Why Ortopedija Bedenčič.

Slovenia

Ortopedija Bedenčič

Slovenian sports bodies

7 hospitals and the Port of Koper

The Adriatic care network.

What Vogler Med coordinates

Orthopaedic and surgical

Specialist diagnostics

Rehabilitation

Regenerative medicine

Medical care for cruise passengers.

Assess and treat

Assess and escort

Waiting too long for a procedure?

Authorised CEE distributor. Physician‑led from day one.

End-to-end distribution. No gaps.

Regulatory infrastructure

Clinical introduction

Hospital access and tendering

Logistics and traceability

Reimbursement navigation

Regional expansion

The team behind every partnership.

Jan Vogler, dr. med.

Prof. Igor D. Gregorič, MD, FACC

Three core markets, one expansion path.

Slovenia, Croatia and Austria

Western Balkans and CEE

Athlete pathwayPillars 1 and 2

General client pathwayPillar 3